1832 Asset Management
VRTX icon

1832 Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,630
Closed -$2.17M 909
2024
Q2
$2.17M Sell
4,630
-1,150
-20% -$539K ﹤0.01% 480
2024
Q1
$2.42M Sell
5,780
-512
-8% -$214K ﹤0.01% 458
2023
Q4
$2.56M Buy
6,292
+770
+14% +$313K ﹤0.01% 440
2023
Q3
$1.92M Buy
5,522
+834
+18% +$290K ﹤0.01% 486
2023
Q2
$1.65M Sell
4,688
-1,606
-26% -$565K ﹤0.01% 520
2023
Q1
$1.98M Sell
6,294
-1,190
-16% -$375K ﹤0.01% 506
2022
Q4
$2.16M Sell
7,484
-41,441
-85% -$12M ﹤0.01% 505
2022
Q3
$14.2M Buy
48,925
+236
+0.5% +$68.3K 0.03% 310
2022
Q2
$13.7M Buy
+48,689
New +$13.7M 0.02% 305
2022
Q1
Hold
0
965
2021
Q4
Sell
-84,040
Closed -$15.4M 867
2021
Q3
$15.4M Sell
84,040
-57,165
-40% -$10.4M 0.03% 287
2021
Q2
$27.4M Buy
141,205
+126,205
+841% +$24.5M 0.05% 229
2021
Q1
$3.21M Sell
15,000
-35,300
-70% -$7.55M 0.01% 376
2020
Q4
$11.7M Sell
50,300
-724,100
-94% -$169M 0.03% 272
2020
Q3
$209M Sell
774,400
-290,200
-27% -$78.3M 0.55% 57
2020
Q2
$304M Buy
1,064,600
+54,700
+5% +$15.6M 0.91% 26
2020
Q1
$233M Buy
1,009,900
+333,900
+49% +$77.1M 0.84% 31
2019
Q4
$147M Buy
676,000
+477,600
+241% +$104M 0.45% 64
2019
Q3
$32.4M Buy
198,400
+164,200
+480% +$26.8M 0.1% 154
2019
Q2
$6.12M Sell
34,200
-173,300
-84% -$31M 0.02% 278
2019
Q1
$36.8M Sell
207,500
-492,100
-70% -$87.2M 0.13% 148
2018
Q4
$114M Sell
699,600
-204,925
-23% -$33.4M 0.45% 59
2018
Q3
$172M Buy
904,525
+708,025
+360% +$135M 0.56% 48
2018
Q2
$32.6M Sell
196,500
-824,000
-81% -$137M 0.11% 151
2018
Q1
$165M Buy
1,020,500
+39,400
+4% +$6.37M 0.61% 47
2017
Q4
$145M Buy
981,100
+70,398
+8% +$10.4M 0.47% 57
2017
Q3
$133M Buy
910,702
+383,402
+73% +$55.8M 0.46% 56
2017
Q2
$66.6M Buy
+527,300
New +$66.6M 0.3% 77
2015
Q1
Sell
-668,900
Closed -$78.4M 690
2014
Q4
$78.4M Buy
668,900
+325,140
+95% +$38.1M 0.24% 101
2014
Q3
$38.3M Buy
343,760
+202,960
+144% +$22.6M 0.12% 159
2014
Q2
$13.3M Buy
+140,800
New +$13.3M 0.04% 265
2013
Q3
Sell
-50,900
Closed -$4.06M 427
2013
Q2
$4.06M Buy
+50,900
New +$4.06M 0.02% 289